The President of the Etablissement Français du Sang shall send the Director General of the Agence Nationale de Sécurité du Médicament et des Produits de Santé a copy of any instrument appointing the person in charge and the interim persons in charge.
When the person in charge is temporarily replaced, the President of the Etablissement Français du Sang shall immediately inform the Director General of the Agency of the name and date of commencement of duties of the interim person in charge whom he has designated.